Works matching AU Nakayama, Takahiro

Results: 147
    1
    2
    3

    Phase II Trial in Japan of Sequential Administration of Weekly Paclitaxel Followed by FEC as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer [KBCSG0206 Trial: Kinki Breast Cancer Study Group (KBCSG)].

    Published in:
    Oncology, 2010, v. 78, n. 5/6, p. 302, doi. 10.1159/000318169
    By:
    • Taguchi, Tetsuya;
    • Masuda, Norikazu;
    • Nakayama, Takahiro;
    • Motomura, Kazuyoshi;
    • Tsukamoto, Fumine;
    • Shimazu, Kenzo;
    • Nomura, Takashi;
    • Morimoto, Takashi;
    • Yamamoto, Hiroshi;
    • Wakita, Kazuyuki;
    • Nakano, Yoshiaki;
    • Yoneda, Kohri;
    • Inaji, Hideo;
    • Takatsuka, Yuichi;
    • Noguchi, Shinzaburo
    Publication type:
    Article
    4
    5
    6
    7

    Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 203, doi. 10.1093/jjco/hyac184
    By:
    • Kawaguchi, Hidetoshi;
    • Yamamoto, Yutaka;
    • Saji, Shigehira;
    • Masuda, Norikazu;
    • Nakayama, Takahiro;
    • Aogi, Kenjiro;
    • Anan, Keisei;
    • Ohtani, Shoichiro;
    • Sato, Nobuaki;
    • Takano, Toshimi;
    • Tokunaga, Eriko;
    • Nakamura, Seigo;
    • Hasegawa, Yoshie;
    • Hattori, Masaya;
    • Fujisawa, Tomomi;
    • Morita, Satoshi;
    • Yamaguchi, Miki;
    • Yamashita, Toshinari;
    • Yotsumoto, Daisuke;
    • Toi, Masakazu
    Publication type:
    Article
    8

    Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 6, p. 545, doi. 10.1093/jjco/hyac022
    By:
    • Kawaguchi, Hidetoshi;
    • Yamamoto, Yutaka;
    • Saji, Shigehira;
    • Masuda, Norikazu;
    • Nakayama, Takahiro;
    • Aogi, Kenjiro;
    • Anan, Keisei;
    • Ito, Yoshinori;
    • Ohtani, Shoichiro;
    • Sato, Nobuaki;
    • Takano, Toshimi;
    • Tokunaga, Eriko;
    • Nakamura, Seigo;
    • Hasegawa, Yoshie;
    • Hattori, Masaya;
    • Fujisawa, Tomomi;
    • Morita, Satoshi;
    • Yamaguchi, Miki;
    • Yamashita, Hiroko;
    • Yamashita, Toshinari
    Publication type:
    Article
    9
    10

    Evaluation of Trastuzumab Without Chemotherapy as a Post-operative Adjuvant Therapy in HER2-positive Elderly Breast Cancer Patients: Randomized Controlled Trial [RESPECT (N-SAS BC07)]†.

    Published in:
    Japanese Journal of Clinical Oncology, 2011, v. 41, n. 5, p. 709, doi. 10.1093/jjco/hyr011
    By:
    • Sawaki, Masataka;
    • Tokudome, Nahomi;
    • Mizuno, Toshiro;
    • Nakayama, Takahiro;
    • Taira, Naruto;
    • Bando, Hiroko;
    • Murakami, Shigeru;
    • Yamamoto, Yutaka;
    • Kashiwaba, Masahiro;
    • Iwata, Hiroji;
    • Uemura, Yukari;
    • Ohashi, Yasuo
    Publication type:
    Article
    11

    Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214.

    Published in:
    Cancers, 2021, v. 13, n. 17, p. 4399, doi. 10.3390/cancers13174399
    By:
    • Masuda, Norikazu;
    • Yoshinami, Tetsuhiro;
    • Ikeda, Masahiko;
    • Mizutani, Makiko;
    • Yamaguchi, Miki;
    • Komoike, Yoshifumi;
    • Takashima, Tsutomu;
    • Yoshidome, Katsuhide;
    • Tsurutani, Junji;
    • Iwamoto, Mitsuhiko;
    • Fujisawa, Fumie;
    • Yasojima, Hiroyuki;
    • Yamamura, Jun;
    • Morishima, Hirotaka;
    • Aki, Fuminori;
    • Yamada, Tomomi;
    • Morita, Satoshi;
    • Nakayama, Takahiro
    Publication type:
    Article
    12
    13
    14
    15
    16

    Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia.

    Published in:
    Journal of Inherited Metabolic Disease, 2018, v. 41, n. 5, p. 777, doi. 10.1007/s10545-018-0176-1
    By:
    • Hayasaka, Kiyoshi;
    • Numakura, Chikahiko;
    • Yamakawa, Mitsunori;
    • Mitsui, Tetsuo;
    • Watanabe, Hisayoshi;
    • Haga, Hiroaki;
    • Yazaki, Masahide;
    • Ohira, Hiromasa;
    • Ochiai, Yasuo;
    • Tahara, Toshiyuki;
    • Nakahara, Tamio;
    • Yamashiki, Noriyo;
    • Nakayama, Takahiro;
    • Kon, Takashi;
    • Mitsubuchi, Hiroshi;
    • Yoshida, Hiroshi
    Publication type:
    Article
    17
    18
    19
    20
    21
    22

    Preliminary results from ASCENT-J02: a phase 1/2 study of sacituzumab govitecan in Japanese patients with advanced solid tumors.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1684, doi. 10.1007/s10147-024-02589-x
    By:
    • Naito, Yoichi;
    • Nakamura, Seigo;
    • Kawaguchi-Sakita, Nobuko;
    • Ishida, Takanori;
    • Nakayama, Takahiro;
    • Yamamoto, Yutaka;
    • Masuda, Norikazu;
    • Matsumoto, Koji;
    • Kogawa, Takahiro;
    • Sudo, Kazuki;
    • Shimomura, Akihiko;
    • Lai, Catherine;
    • Zhang, Danjie;
    • Iwahori, Yuki;
    • Gary, Dianna;
    • Huynh, Danh;
    • Iwata, Hiroji
    Publication type:
    Article
    23
    24
    25

    Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer.

    Published in:
    International Journal of Clinical Oncology, 2015, v. 20, n. 6, p. 1102, doi. 10.1007/s10147-015-0832-5
    By:
    • Inoue, Kenichi;
    • Kuroi, Katsumasa;
    • Shimizu, Satoru;
    • Rai, Yoshiaki;
    • Aogi, Kenjiro;
    • Masuda, Norikazu;
    • Nakayama, Takahiro;
    • Iwata, Hiroji;
    • Nishimura, Yuichiro;
    • Armour, Alison;
    • Sasaki, Yasutsuna
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.

    Published in:
    2022
    By:
    • Ueno, Takayuki;
    • Kitano, Shigehisa;
    • Masuda, Norikazu;
    • Ikarashi, Daiki;
    • Yamashita, Makiko;
    • Chiba, Tomohiro;
    • Kadoya, Takayuki;
    • Bando, Hiroko;
    • Yamanaka, Takashi;
    • Ohtani, Shoichiro;
    • Nagai, Shigenori;
    • Nakayama, Takahiro;
    • Takahashi, Masato;
    • Saji, Shigehira;
    • Aogi, Kenjiro;
    • Velaga, Ravi;
    • Kawaguchi, Kosuke;
    • Morita, Satoshi;
    • Haga, Hironori;
    • Ohno, Shinji
    Publication type:
    journal article
    43

    Randomized phase II study of nab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.

    Published in:
    Cancer Science, 2017, v. 108, n. 5, p. 987, doi. 10.1111/cas.13221
    By:
    • Tamura, Kenji;
    • Inoue, Kenichi;
    • Masuda, Norikazu;
    • Takao, Shintaro;
    • Kashiwaba, Masahiro;
    • Tokuda, Yutaka;
    • Iwata, Hiroji;
    • Yamamoto, Naohito;
    • Aogi, Kenjiro;
    • Saeki, Toshiaki;
    • Nakayama, Takahiro;
    • Sato, Nobuaki;
    • Toyama, Tatsuya;
    • Ishida, Takanori;
    • Arioka, Hitoshi;
    • Saito, Mitsue;
    • Ohno, Shinji;
    • Yamauchi, Hideko;
    • Yamada, Kimito;
    • Watanabe, Junichiro
    Publication type:
    Article
    44

    Randomized phase II study of three doses of oral TAS-108 in postmenopausal patients with metastatic breast cancer.

    Published in:
    Cancer Science, 2012, v. 103, n. 9, p. 1708, doi. 10.1111/j.1349-7006.2012.02354.x
    By:
    • Inaji, Hideo;
    • Iwata, Hiroji;
    • Nakayama, Takahiro;
    • Yamamoto, Naohito;
    • Sato, Yasuyuki;
    • Tokuda, Yutaka;
    • Aogi, Kenjiro;
    • Saji, Shigehira;
    • Watanabe, Kenichi;
    • Saito, Tsuyoshi;
    • Yoshida, Masayuki;
    • Sato, Nobuaki;
    • Saeki, Toshiaki;
    • Takatsuka, Yuichi;
    • Kuranami, Masaru;
    • Yamashita, Hiroko;
    • Kikuchi, Atsushi;
    • Tabei, Toshio;
    • Ikeda, Tadashi;
    • Noguchi, Shinzaburo
    Publication type:
    Article
    45
    46
    47
    48
    49

    Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 741, doi. 10.1007/s00280-012-2068-7
    By:
    • Taguchi, Tetsuya;
    • Yamamoto, Daigo;
    • Masuda, Norikazu;
    • Oba, Koji;
    • Nakayama, Takahiro;
    • Nagata, Takuya;
    • Nomura, Masaya;
    • Yoshidome, Katsuhide;
    • Yoshino, Hiroshi;
    • Matsunami, Nobuki;
    • Miyashita, Masaru;
    • Furuya, Yoshihiko;
    • Ishida, Takanori;
    • Wakita, Kazuyuki;
    • Sakamoto, Junichi;
    • Noguchi, Shinzaburo
    Publication type:
    Article
    50

    Long-Term Survival Outcomes and Risk Factors for Axillary and Locoregional Recurrence in Japanese Patients with Sentinel Node-Positive Breast Cancer Treated in Accordance with the ACOSOG Z0011 Strategy.

    Published in:
    Oncology, 2025, v. 103, n. 2, p. 143, doi. 10.1159/000540363
    By:
    • Oyama, Yuri;
    • Kittaka, Nobuyoshi;
    • Higuchi, Ayako;
    • Togashi, Yusa;
    • Taniguchi, Azusa;
    • Seto, Yukiko;
    • Soma, Ai;
    • Park, Sungae;
    • Okuno, Jun;
    • Watanabe, Noriyuki;
    • Matsui, Saki;
    • Ishihara, Mikiya;
    • Nishio, Minako;
    • Honma, Keiichiro;
    • Nakayama, Takahiro
    Publication type:
    Article